3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
413
Lymphoma
401
Lymphoma, Non-Hodgkin
337
Leukemia, Lymphocytic, Chronic, B-Cell
302
Lymphoma, Follicular
295
Lymphoma, Mantle-Cell
225
Lymphoma, B-Cell, Marginal Zone
159
Leukemia
119
Lymphoma, B-Cell
112
Burkitt Lymphoma
110
Waldenstrom Macroglobulinemia
99
Precursor Cell Lymphoblastic Leukemia-Lymphoma
90
Recurrence
83
Hodgkin Disease
60
Lymphoma, Large-Cell, Immunoblastic
57
Neoplasms
39
Multiple Myeloma
26
Lymphoma, Large-Cell, Anaplastic
26
Myelodysplastic Syndromes
25
Leukemia, Myeloid, Acute
24
Dendritic Cell Sarcoma, Interdigitating
22
Hematologic Neoplasms
21
Leukemia, Hairy Cell
20
Intraocular Lymphoma
17
Leukemia, Prolymphocytic
16
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
14
Lymphoma, T-Cell
14
Neoplasms, Plasma Cell
13
Lymphoproliferative Disorders
12
Hematologic Diseases
12
Interventions
cabozantinib
1
belimumab
1
Specimen Handling
1
Rituximab
1
Platinum Compounds
1
Nivolumab
1
Ipilimumab
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Sjogren's Syndrome
×
Rituximab
×
Clear all
NCT06410833
2024-05-16
BRRPJS
Peking Union Medical College Hospital
Phase 4
Recruiting
15 enrolled